Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 May 2026 for Zentalis Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Shannon Campbell: trading record in brief
This profile gathers the share dealings of Shannon Campbell across 2 companies, led by Black Diamond Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. Between 21 June 2024 and 26 May 2026, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 27 May 2026 came the latest disclosure, a share grant in Zentalis Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shannon Campbell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
114,200 shares0Common StockSEC:0002018966-26-000005:0
4,500 shares@ US$2.5035.6% of flowCommon StockSEC:0001415889-24-029481:0
2,354 shares@ US$4.7833.4% of flowCommon StockSEC:0001415889-24-023757:0
2,011 shares@ US$4.9831.0% of flowCommon StockSEC:0001415889-24-017842:0
4 of 4 declarations
